Open Access

Mangiferin positively regulates osteoblast differentiation and suppresses osteoclast differentiation

  • Authors:
    • Yuusuke Sekiguchi
    • Hiroshi Mano
    • Sachie Nakatani
    • Jun Shimizu
    • Aya Kataoka
    • Kana Ogura
    • Yoshifumi Kimira
    • Midori Ebata
    • Masahiro Wada
  • View Affiliations

  • Published online on: June 12, 2017     https://doi.org/10.3892/mmr.2017.6752
  • Pages: 1328-1332
  • Copyright: © Sekiguchi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Mangiferin is a polyphenolic compound present in Salacia reticulata. It has been reported to reduce bone destruction and inhibit osteoclastic differentiation. This study aimed to determine whether mangiferin directly affects osteoblast and osteoclast proliferation and differentiation, and gene expression in MC3T3‑E1 osteoblastic cells and osteoclast‑like cells derived from primary mouse bone marrow macrophage cells. Mangiferin induced significantly greater WST‑1 activity, indicating increased cell proliferation. Mangiferin induced significantly increased alkaline phosphatase staining, indicating greater cell differentiation. Reverse transcription‑polymerase chain reaction (RT‑PCR) demonstrated that mangiferin significantly increased the mRNA level of runt‑related transcription factor 2 (RunX2), but did not affect RunX1 mRNA expression. Mangiferin significantly reduced the formation of tartrate‑resistant acid phosphatase‑positive multinuclear cells. RT‑PCR demonstrated that mangiferin significantly increased the mRNA level of estrogen receptor β (ERβ), but did not affect the expression of other osteoclast‑associated genes. Mangiferin may inhibit osteoclastic bone resorption by suppressing differentiation of osteoclasts and promoting expression of ERβ mRNA in mouse bone marrow macrophage cells. It also has potential to promote osteoblastic bone formation by promoting cell proliferation and inducing cell differentiation in preosteoblast MC3T3‑E1 cells via RunX2. Mangiferin may therefore be useful in improving bone disease outcomes.
View Figures
View References

Related Articles

Journal Cover

August-2017
Volume 16 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

The Cancer Story
Copy and paste a formatted citation
x
Spandidos Publications style
Sekiguchi Y, Mano H, Nakatani S, Shimizu J, Kataoka A, Ogura K, Kimira Y, Ebata M and Wada M: Mangiferin positively regulates osteoblast differentiation and suppresses osteoclast differentiation. Mol Med Rep 16: 1328-1332, 2017
APA
Sekiguchi, Y., Mano, H., Nakatani, S., Shimizu, J., Kataoka, A., Ogura, K. ... Wada, M. (2017). Mangiferin positively regulates osteoblast differentiation and suppresses osteoclast differentiation. Molecular Medicine Reports, 16, 1328-1332. https://doi.org/10.3892/mmr.2017.6752
MLA
Sekiguchi, Y., Mano, H., Nakatani, S., Shimizu, J., Kataoka, A., Ogura, K., Kimira, Y., Ebata, M., Wada, M."Mangiferin positively regulates osteoblast differentiation and suppresses osteoclast differentiation". Molecular Medicine Reports 16.2 (2017): 1328-1332.
Chicago
Sekiguchi, Y., Mano, H., Nakatani, S., Shimizu, J., Kataoka, A., Ogura, K., Kimira, Y., Ebata, M., Wada, M."Mangiferin positively regulates osteoblast differentiation and suppresses osteoclast differentiation". Molecular Medicine Reports 16, no. 2 (2017): 1328-1332. https://doi.org/10.3892/mmr.2017.6752